TITLE

Merck Touts Pipeline

PUB. DATE
December 2011
SOURCE
Pharmaceutical Representative;Dec2011, Vol. 41 Issue 12, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the growth and developments of pharmaceutical company Merck & Co. Inc., discussing its products, expansions, and business plans in the U.S.
ACCESSION #
69647445

 

Related Articles

  • M&A fever.  // Pharmaceutical Representative;Apr2009, Vol. 39 Issue 4, p8 

    The article reports on the acquisition of Schering-Plough Corp. by Merck & Co. Inc. It mentions that Merck has refused to get consolidated with other pharmaceutical companies for several times and cites its decision to procure Schering worth $41 billion. Furthermore, Merck's deal with Schering...

  • Expansion.  // BioPharm International;May2004, Vol. 17 Issue 5, p13 

    Cites several business expansions in the pharmaceutical industry in the U.S. as of May 2004. Insmed's acquisition of a recombinant protein manufacturing facility formerly operated by Baxter International in Boulder, Colorado; Merck's plan to construct a vaccine manufacturing plant in North...

  • Bayer Cures Merck Headache, Buys Consumer Unit For $14.2 Bil. AMY REEVES // Investors Business Daily;5/ 7/2014, pA15 

    Merck agreed to sell its consumer business to German giant Bayer for $14.2 billion Tuesday, continuing big pharma's recent flurry of big deals.

  • Specify MERCK.  // Canadian Chemical News;Nov/Dec2014, p44 

    The article focuses on Merck & Co. Inc., a pharmaceutical company founded by German apothecary Friedrich Jacob Merck in 1668. Topics discused include the raw materials provided by the company including alkaloids, the business expansion, and the significant impact of the World wars in the...

  • Merck postpones PBM spinoff amid accounting questions. Mcleod, Douglas // Business Insurance;7/15/2002, Vol. 36 Issue 28, p6 

    Reports the launch of the Medco Health Solutions Inc. unit of the pharmaceutical company Merck & Co. Inc. in New York. Condition of the stock market; Financial issues; Deduction in the copayments by the drug company.

  • STOCK TO WATCH: MERCK. Sundaramoorthy, Geeta // Business News New Jersey;12/19/2000, Vol. 13 Issue 51, p17 

    Deals with Whitehouse Station, New Jersey-based pharmaceutical firm Merck & Co. Inc. Research spending for 2001; Estimates of earnings per share in 2001; Five key products.

  • Merck.  // Formulary;Oct2000 Resource Guide, Vol. 35 Issue 10, p59 

    Features the Merck & Co., a pharmaceutical manufacturer. Focus of its research and development efforts; Investment plans for worldwide research and development; Top-producing products; Acquisition of the Sibia Neurosciences, a biotechnology firm; Pharmaceutical products that have received...

  • Merck releases first-quarter 2003 earnings report.  // Caribbean Business;5/1/2003, Vol. 31 Issue 17, p14 

    Reports on release of the first quarter 2003 earnings report of drug manufacturer Merck & Co. Inc. Increase in net income and pharmaceutical sales profit; Sales projections for the rest of the year; Impact of product performance on sales.

  • Pharma: Other News To Note.  // BioWorld Today;3/14/2013, Vol. 24 Issue 49, p6 

    This section offers news briefs on pharmaceutical companies as of March 14, 2013 including a license deal between Merck & Co. Inc. and Luminex Corp. and the plans of Takeda Pharmaceutical Co. and Scripps Research Institute to expand their research partnership.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics